CI vs. ELV, CNC, HUM, VRTX, BSX, REGN, BMY, MDT, SNY, and GILD
Should you be buying The Cigna Group stock or one of its competitors? The main competitors of The Cigna Group include Elevance Health (ELV), Centene (CNC), Humana (HUM), Vertex Pharmaceuticals (VRTX), Boston Scientific (BSX), Regeneron Pharmaceuticals (REGN), Bristol-Myers Squibb (BMY), Medtronic (MDT), Sanofi (SNY), and Gilead Sciences (GILD). These companies are all part of the "medical" sector.
Elevance Health (NYSE:ELV) and The Cigna Group (NYSE:CI) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, community ranking, profitability, earnings, risk, media sentiment, institutional ownership and valuation.
Elevance Health pays an annual dividend of $6.52 per share and has a dividend yield of 1.2%. The Cigna Group pays an annual dividend of $5.60 per share and has a dividend yield of 1.6%. Elevance Health pays out 24.6% of its earnings in the form of a dividend. The Cigna Group pays out 32.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has raised its dividend for 13 consecutive years and The Cigna Group has raised its dividend for 4 consecutive years.
In the previous week, Elevance Health had 40 more articles in the media than The Cigna Group. MarketBeat recorded 57 mentions for Elevance Health and 17 mentions for The Cigna Group. Elevance Health's average media sentiment score of 0.85 beat The Cigna Group's score of 0.83 indicating that The Cigna Group is being referred to more favorably in the news media.
Elevance Health presently has a consensus price target of $587.64, indicating a potential upside of 10.27%. The Cigna Group has a consensus price target of $362.14, indicating a potential upside of 2.68%. Given The Cigna Group's higher probable upside, equities analysts plainly believe Elevance Health is more favorable than The Cigna Group.
Elevance Health has higher earnings, but lower revenue than The Cigna Group. Elevance Health is trading at a lower price-to-earnings ratio than The Cigna Group, indicating that it is currently the more affordable of the two stocks.
89.2% of Elevance Health shares are held by institutional investors. Comparatively, 87.0% of The Cigna Group shares are held by institutional investors. 0.3% of Elevance Health shares are held by insiders. Comparatively, 0.7% of The Cigna Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Elevance Health has a net margin of 3.64% compared to Elevance Health's net margin of 2.64%. The Cigna Group's return on equity of 20.62% beat Elevance Health's return on equity.
Elevance Health has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500. Comparatively, The Cigna Group has a beta of 0.56, suggesting that its stock price is 44% less volatile than the S&P 500.
The Cigna Group received 95 more outperform votes than Elevance Health when rated by MarketBeat users. Likewise, 71.82% of users gave The Cigna Group an outperform vote while only 66.61% of users gave Elevance Health an outperform vote.
Summary
Elevance Health beats The Cigna Group on 13 of the 22 factors compared between the two stocks.
Get The Cigna Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for CI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
The Cigna Group Competitors List
Related Companies and Tools
